ÂÜÀòÂÒÂ×

Dominic Piscitelli possesses extensive experience in financial leadership and board governance within the biotechnology and pharmaceutical sectors. Currently serving as the Chief Financial Officer at ORIC Pharmaceuticals and as an Independent Board Member and Audit Committee Chair at Alterome Therapeutics, Dominic has also held pivotal roles including Board Member at Celyad and Chief Financial Officer at AnaptysBio. Previous experience includes senior finance positions at Medivation and Astellas Pharma, as well as an Audit Manager role at KPMG. Dominic holds a Master’s degree in Accounting and Finance from Hofstra University, where undergraduate studies were also completed.